Revenue
2022
2023
2024
2025
Dogwood Therapeutics, Inc. (DWTX)
Price$2.29Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $21.9M | $3.5M | $1.7M | $8.1M | $10.8M | $194,013 |
| Operating expenses | $28.0M | $12.2M | $5.4M | $12.3M | $15.6M | $10.0M |
| Operating income | −$28.0M | −$12.2M | −$5.4M | −$12.3M | −$15.6M | −$10.0M |
| EBITDA | −$28.0M | −$12.2M | −$5.4M | −$12.3M | — | — |
| Net income | −$34.3M | −$12.3M | −$5.3M | −$12.2M | −$16.0M | −$10.3M |
| Basic EPSper basic share | -$7.13 | -$12.52 | -$7.05 | -$27.75 | -$48.00 | -$52.50 |
| Diluted EPSper diluted share | -$7.13 | -$12.52 | -$7.05 | -$27.75 | -$48.00 | -$52.50 |
Owners
Reported shareholders
≈73.34%of listed shares
Conjoint Inc. / CK Life Sciences Intl (Holdings) Inc / Sealbond Ltd24.66M shares · Nov 21, 2025
View holders
| Holder | % owned |
|---|---|
Conjoint Inc. / CK Life Sciences Intl (Holdings) Inc / Sealbond Ltd | ≈73.34%24.66M shares |
ARMISTICE CAPITAL, LLC | 9.31%3.13M shares |
MILLENNIUM MANAGEMENT LLC | 1.02%341.81K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.39%132.15K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.26%88.3K shares |
VANGUARD FIDUCIARY TRUST CO | 0.19%62.74K shares |
BlackRock, Inc. | 0.08%28.55K shares |
NORTHERN TRUST CORP | 0.07%23.78K shares |
CITADEL ADVISORS LLC | 0.03%11.74K shares |
Tower Research Capital LLC (TRC) | <0.01%3.09K shares |
MORGAN STANLEY | <0.01%2.22K shares |
UBS Group AG | <0.01%1.86K shares |
JONES FINANCIAL COMPANIES LLLP | <0.01%160 shares |
BARCLAYS PLC | <0.01%157 shares |
Activest Wealth Management | <0.01%120 shares |
GROUP ONE TRADING LLC | <0.01%9 shares |
Percentages use 33.63M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data